FDA Recalls Zantac
The U.S. Food and Drug Adminstration announced this week that it will pull ranitidine drugs (Zantac) from the market. According to the agency, it is removing these drugs because of an impurity issue. Learn more here.
Source: ENT Today - Category: ENT & OMF Authors: Stephanie Cajigal Tags: News Online Exclusives FDA Source Type: research